Industry Welcomes Support From UK Life Sciences Plan

Off-Patent Sector Praises Inclusion Of Specific Measures On Generics And Biosimilars

 
• By Dave Wallace
  
Medicines UK welcomed the recognition of off-patent medicines (Shutterstock)

More from Policy & Regulation

More from Generics Bulletin